Ameridose Demonstrates Commitment to Customer Care Excellence
Westborough, MA, April 23, 2011 --(PR.com)-- Ameridose, LLC, a leading nationwide provider of sterile admixing services to hospital pharmacies, demonstrates its unrelenting commitment to customer care excellence through the appointment of Mr. Todd DeAngelis to serve as Vice President of Innovation and Customer Experience. He is charged with leading Ameridose to new standards of excellence around customer experience and ease of doing business. In addition, Mr. DeAngelis will evaluate company-wide processes to ensure that Ameridose continues to incorporate client service best practices and the latest innovative techniques and technologies.
Mr. DeAngelis stated, “I am extremely excited to be taking on this role for Ameridose. Their focus on service has always been a hallmark of the organization. I look forward to driving continuous customer experience improvement to ensure that Ameridose remains an industry leader and is constantly on the cutting-edge of customer-facing technology.”
Mr. DeAngelis has held customer-focused leadership positions in healthcare, pharmaceuticals and medical technology for many years. Previously, at Thomson-Reuters, he analyzed customer needs, translating these into new product requirements and specifications, resulting in multi-million dollar healthcare, pharmaceutical, and technology releases. Prior to Thomson-Reuters, Mr. DeAngelis managed a decision support line of products for the obstetrics market at LMS Medical Systems, a medical technology company. Before joining LMS, he served as Marketing and Sales Director for Inflexxion, a healthcare education technology company, managing several significant technology projects for leading pharmaceutical and biotechnology organizations.
About Ameridose, LLC
Ameridose (www.Ameridose.com) is a leading provider of high quality sterile admixed and repackaged preparations and oral repackaging services to hospital pharmacies nationwide. Ameridose, an FDA registered manufacturer, exceeds USP <797> standards and meets cGMP requirements. Committed to delivering the finest outsourcing services in the industry, Ameridose considers quality, exceptional customer service, and value to be central elements of its corporate mission.
###
Mr. DeAngelis stated, “I am extremely excited to be taking on this role for Ameridose. Their focus on service has always been a hallmark of the organization. I look forward to driving continuous customer experience improvement to ensure that Ameridose remains an industry leader and is constantly on the cutting-edge of customer-facing technology.”
Mr. DeAngelis has held customer-focused leadership positions in healthcare, pharmaceuticals and medical technology for many years. Previously, at Thomson-Reuters, he analyzed customer needs, translating these into new product requirements and specifications, resulting in multi-million dollar healthcare, pharmaceutical, and technology releases. Prior to Thomson-Reuters, Mr. DeAngelis managed a decision support line of products for the obstetrics market at LMS Medical Systems, a medical technology company. Before joining LMS, he served as Marketing and Sales Director for Inflexxion, a healthcare education technology company, managing several significant technology projects for leading pharmaceutical and biotechnology organizations.
About Ameridose, LLC
Ameridose (www.Ameridose.com) is a leading provider of high quality sterile admixed and repackaged preparations and oral repackaging services to hospital pharmacies nationwide. Ameridose, an FDA registered manufacturer, exceeds USP <797> standards and meets cGMP requirements. Committed to delivering the finest outsourcing services in the industry, Ameridose considers quality, exceptional customer service, and value to be central elements of its corporate mission.
###
Contact
Ameridose
Elizabeth Atkin
508-656-2651
www.ameridose.com
Contact
Elizabeth Atkin
508-656-2651
www.ameridose.com
Categories